Johnson Chemical Pharmaceutical Works Co., Ltd.
Research Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO) on Bullrun: market cap TWD 2.13B, P/E 23.9, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4747.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 2.13B
- P/E23.9
- Dividend yield3.3%
- Financial periodQ2 2026
- RevenueTWD 146.54M
- Net incomeTWD 10.44M
- Free cash flowTWD 2.20M
- Gross margin37.2%
Valuation Snapshot
latest market cap is TWD 2.13B; P/E is 23.9; dividend yield is 3.3%.
Peer valuation comparison
Latest P/E is 23.93x versus a Healthcare sector median of 21.8x (9.8% above).
Latest dividend yield is 3.32% versus a Healthcare sector median of 2.4% (38.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.13B | 23.9 | 2.2% | 0.53 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.53 TWD, yield 3.3%.
About Johnson Chemical Pharmaceutical Works Co., Ltd.
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc.
ETFs that hold Johnson Chemical Pharmaceutical Works Co., Ltd.
US-listed ETFs
Johnson Chemical Pharmaceutical Works Co., Ltd. is held by one US-listed ETF, going by the latest portfolio it filed with the SEC:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Johnson Chemical Pharmaceutical Works Co., Ltd.'s market cap?
Johnson Chemical Pharmaceutical Works Co., Ltd.'s market capitalization is TWD 2.13B.
What is Johnson Chemical Pharmaceutical Works Co., Ltd.'s P/E ratio?
Johnson Chemical Pharmaceutical Works Co., Ltd.'s price-to-earnings (P/E) ratio is 23.9.
Does Johnson Chemical Pharmaceutical Works Co., Ltd. pay a dividend?
Johnson Chemical Pharmaceutical Works Co., Ltd. has a dividend yield of 3.3%.
What does Johnson Chemical Pharmaceutical Works Co., Ltd. do?
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is based in New Taipei City, Taiwan.